Emil Lou, MD,PhD,FACP
banner
cancerassassin1.bsky.social
Emil Lou, MD,PhD,FACP
@cancerassassin1.bsky.social
Physician-Scientist/Clinical Cancer Biologist/GI Medical Oncologist. In lab: Cancer Cell Biology, uncovering how #TunnelingNanotubes drive ChemoResistance. https://med.umn.edu/dom/divisions/hematology-oncology-and-transplantation/research/emil-lou-lab
On this date in history, 1969: #SesameStreet debuted on @pbs.org

Through the creators and cast we learned compassion, kindness, and many other ways to be in life. The world can use more of what Sesame Street has taught us over the last half-century plus.
November 10, 2025 at 5:54 PM
The NIH has posted that it "seeks exceptional senior-level candidates to lead Institutes and the Intramural Research Program within the NIH."
A rather comprehensive list of nearly all major Directorships one thinks of in science. Unfilled, with close dates that are approaching within 2 weeks.
November 7, 2025 at 10:57 PM
Looking forward to the next episode of #ConnectOvarCoffee ☕️where I will join Runsi Sen from #ovariancancer advocacy organization Ovarcome to
talk about Breaking the Code and Disrupting Cellular Communication for Ovarcoming #ovariancancer.
Nov 13 LIVE on #YouTube www.youtube.com/channel/UCn8...
November 6, 2025 at 2:21 PM
October 31, 2025 at 8:15 PM
Performing some team teaching today on Neuroendocrine Cancers by sharing this excellent figure from 2024 expert consensus statement by Drs. Chauhan et al
@cacancerjournal.bsky.social acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
October 7, 2025 at 3:12 PM
Fascinating bit of the history of #oncology that came to my attention recently:

The world's oldest known cancerous tumor - 1.7 million years! from Swartkrans Cave, South Africa - with rendering included in this 2016 publication
sajs.co.za/article/view...
October 4, 2025 at 1:05 PM
#TunnelingNanotubes are membranous extensions of cells that mediate cell contact-dependent intercellular transport of organelles and viruses. In our recent study of SARS-CoV-2 in tissue from patients, we found them in post-infected samples from matched tissue specimens. www.cell.com/iscience/ful...
October 4, 2025 at 1:04 PM
September 11, 2025 at 1:42 PM
From our U of MN Medical School research team: press release highlighting our recent publication in @cellpress.bsky.social journal @cp-iscience.bsky.social w/implications for Long COVID in immunocompromised patients with cancer and transplant:

med.umn.edu/news/researc...
#COVID #LongCOVID
September 10, 2025 at 5:50 PM
From our team, in @cp-iscience.bsky.social: SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer. Potential implications for Long COVID syndrome and overlap with GVHD in patients w/stem cell transplants. www.cell.com/iscience/ful...
August 28, 2025 at 2:59 PM
I'll be posting more about this post-proof, but the pre-proof version is now online @cp-iscience.bsky.social and we are thrilled to get this story out: SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer.
www.cell.com/iscience/ful...
August 26, 2025 at 11:45 AM
Interested in Neuroendocrine Tumors and want to pitch a Regional Conference for your area for 2026?

@nanets.bsky.social has extended the deadline for applications to next week, August 22.

See this link for more details and complete the intake survey:
www.surveymonkey.com/r/TJM3P8M
August 15, 2025 at 2:02 PM
CRISPR-Cas9–Edited Tumor-Infiltrating Lymphocytes in Metastatic Colorectal Cancer - in The ASCO Post @ascopost.bsky.social @ascocancer.bsky.social
ascopost.com/issues/june-...
June 13, 2025 at 6:38 PM
Congratulations to first-author Dr. Gaurav Sharma who is completing his heme-onc fellowship this month at the University of South Alabama! Paper on uncovering IO biomarkers for anal cancers - published today
@myesmo.bsky.social journal ESMO Open www.sciencedirect.com/science/arti...
June 10, 2025 at 8:31 PM
Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools
Our review article #openaccess @cellpress.bsky.social @asgct.bsky.social @moltherapy.bsky.social Oncology
AI is the present+future!
www.cell.com/molecular-th...
June 9, 2025 at 5:59 PM
GI Cancers took center stage at #ASCO25 (figuratively and literally!). Here, our #OnlyOncs team broke down the details on a Phase III trial in stages I-III pancreatic carcinomas, comparing standard mFOLFIRINOX chemo to PAXG. @shaalanbeg.bsky.social @shrutipatelmd.bsky.social @onclive.bsky.social
June 3, 2025 at 12:35 AM
Great way to end the session for the Developmental Therapeutics-Molecularly Targeted Agents & Tumor Biology Track. Congratulations to the Chairs + special thanks to the Investigators for the ctDNA block who allowed me the honor of serving as Discussant of their work #ASCO25 @ascocancer.bsky.social
May 31, 2025 at 12:16 AM
Thank you @onclive.bsky.social for this thorough review of our recent clinical trial for patients with metastatic GI cancers. Looking forward to more #GICancer #OncClub discussions to follow over the next few days at #ASCO25!
@thelancetoncol.bsky.social: www.sciencedirect.com/science/arti...
May 29, 2025 at 8:19 PM
On the cusp of #ASCO25, article from The Cancer Letter details the recent announcement of #AI to searching resources for evidence-based #oncology from @ascocancer.bsky.social
cancerletter.com/clinical/202...
May 29, 2025 at 1:33 PM
I’m looking forward to making new connections at #ASCO25. There’s no better place to be inspired by the ideas driving innovation in cancer care. @ascocancer.bsky.social
May 28, 2025 at 9:28 PM
Can we take a moment to recognize the important work the
National Cancer Institute social media team has done over the years, educating the public about advances in #cancerresearch that have moved the needle -sometimes incremental, other times w/big steps - toward the goal of saving lives. #ASCO25
May 28, 2025 at 3:30 PM
Well ahead of #ASCO25 where Dr. Anant Madabhushi will present advances in AI in #oncology: our joint review Quantitative and Qualitative Metrics of Tumor-Stroma in Predicting Ovarian Cancer Outcomes and Expansion of its Study with AI-Based Tools @moltherapy.bsky.social www.cell.com/molecular-th...
May 24, 2025 at 1:31 PM
Profound anecdote from the obituary of Dr. G. Ralph Corey, legendary longtime Director of the Duke Internal Medicine Residency Program for 18 years. Renowned for an encyclopedic knowledge as well as his tour de force #meded for generations of Duke-trained physicians. www.legacy.com/us/obituarie...
May 15, 2025 at 7:32 PM